Discover
BHST
BioHarvest Sciences Inc.
1.66
1 x 2.14
1 x 2.28
bid
ask
+
0.16
11.04%
1 @ 04:08 PM
1.69 +0.03 (1.81%)
| Ytd | -68.02% | |
| 1y | -86.20% |
1.45
day range
1.69
1.45
52 week range
12.65
| Open | 1.51 | Prev Close | 1.50 | Low | 1.45 | High | 1.69 | Mkt Cap | 37.63M |
| Vol | 17.15K | Avg Vol | 50.56K | EPS | -0.51 | P/E | N/A | Forward P/E | N/A |
| Beta | 1.49 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 1.85 | 200-d Avg | 3.53 | 1yr Est | 14.67 |
BHST News
proactiveinvestors.com
BioHarvest says its platform can produce target sweetener in Tate & Lyle program
BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) said on Thursday its Botanical Synthesis platform ca
newsfilecorp.com
Tate & Lyle and Bioharvest Reach Key Milestone in Next-Generation Sweetener Development Programme
Progress demonstrates that BioHarvest's Botanical Synthesis(TM) platform is capable of producing the
benzinga.com
BioHarvest Sciences Board Authorizes Normal Course Issuer Bid To Repurchase Up To 5% Of Outstanding
BioHarvest Sciences Inc. (NASDAQ:BHST) (TASE: BHST) (FSE: 8MV0) ("BioHarvest" or the "Co